Amarin Steps Closer To EU Cardiovascular Risk Market

 
• By Neena Brizmohun

The European Medicines Agency has recommended in favor of approval for Amarin’s fish-oil derivative, Vazkepa.

Anatomy of Human Heart
Vazkepa is for treating patients at high cardiovascular risk • Source: Shutterstock

More from Europe

More from Geography